Zhang; Deyi

Patent Applications and Registrations

Patent applications and USPTO patent grants for Zhang; Deyi.The latest application filed is for "methods and apparatus for load and route assignments in a delivery system".

Company Profile

4.16.19

Zhang; Deyi - Wuhan CN
Zhang; Deyi - Fremont CA
Zhang; Deyi - Taicang CN
Zhang; Deyi - Beijing CN
ZHANG; Deyi - Taicang City CN
Zhang; Deyi - Carmel IN
Zhang; Deyi - US

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Ferroelectric enhanced solar cell and preparation method thereof Grant 11,127,535 - Han , et al. September 21, 2	2021-09-21
Methods and apparatus for load and route assignments in a delivery system Grant 10,775,182 - Fu , et al. Sept	2020-09-15
Methods And Apparatus For Load And Route Assignments In A Delivery System App 20200082335 - Fu; Mingang ; et al.	2020-03-12
Methods And Apparatus For Load And Route Assignments In A Delivery System App 20200080854 - Fu; Mingang ; et al.	2020-03-12
Ferroelectric Enhanced Solar Cell And Preparation Method Thereof App 20200051753 - HAN; Hongwei ; et al.	2020-02-13
ALK kinase inhibitor, and preparation method and uses thereof Grant 10,023,593 - Dong , et al. July 17, 2	2018-07-17
Cyclopropanecarboxamido-substituted aromatic compounds as anti-tumor agents Grant 9,840,477 - Zhang December 12, 2	2017-12-12
Alk Kinase Inhibitor, And Preparation Method And Uses Thereof App 20170247392 - DONG; Jiaqiang ; et al.	2017-08-31
Pyridinoylpiperidines As 5-HT1F Agonists App 20170044136 - Cohen; Michael Philip ; et al.	2017-02-16
Cyclopropanecarboxamido-Substituted Aromatic Compounds as Anti-tumor Agents App 20160280664 - Zhang; Deyi	2016-09-29
Cyclopropanecarboxamido-substitute aromatic compounds as anti-tumor agents Grant 9,359,338 - Zhang , et al. June 7, 2	2016-06-07
Pyridinoylpiperidines As 5-HT1F Agonists App 20150376178 - Cohen; Michael Philip ; et al.	2015-12-31
Cyclopropanecarboxamido-substitute Aromatic Compounds As Anti-tumor Agents App 20150197511 - Zhang; Deyi ; et al.	2015-07-16
Pyridinoylpiperidines as 5-HT.sub.1F agonists Grant 8,748,459 - Cohen , et al. June 10, 2	2014-06-10
6 substituted 2, 3,4,5 tetrahydro-1H-benzo[d]azepines as 5-HT.sub.2C receptor agonist Grant 8,580,780 - Allen , et al. November 12, 2	2013-11-12
Pyridinoylpiperidines As 5-HT1F Agonists App 20120329820 - Cohen; Michael P. ; et al.	2012-12-27
6 Substituted 2, 3,4,5 Tetrahydro-1H-Benzo[d]Azepines as 5-HT2c Receptor Agonist App 20120028961 - ALLEN; JOHN GORDON ; et al.	2012-02-02
6-substituted 2,3,4,5-tetrahydro-1H-benzo[d]azepines as 5-HT.sub.2C receptor agonists Grant 8,022,062 - Allen , et al. September 20, 2	2011-09-20
6-N-linked heterocycle-substituted 2,3,4,5-tetrahydro-1H-benzo[d]azepines as 5-HT.sub.2C receptor agonists Grant 7,981,882 - Briner , et al. July 19, 2	2011-07-19
Substituted 2-carbonylamino-6-piperidinaminopyridines And Substituted 1-carbonylamino-3-piperidinaminobenzenes As 5-ht1f Agonists App 20110034511 - Blanco-Pillado; Maria-Jesus ; et al.	2011-02-10
Imidazole carboxamides Grant 7,754,742 - Khilevich , et al. July 13, 2	2010-07-13
Imidazole Carboxamides App 20100016373 - Khilevich; Albert ; et al.	2010-01-21
(Piperidinyloxy)phenyl, (piperidinyloxy)pyridinyl, (piperidinylsulfanyl)phenyl and (piperidinylsulfanyl)pyridinyl compounds as 5-HT.sub.1F agonists Grant 7,608,629 - Blanco-Pillado , et al. October 27, 2	2009-10-27
6-substituted 2,3,4,5-tetrahydro-1h-benzo[d]azepines As 5-ht2c Receptor Agonists App 20090099155 - Allen; John Gordon ; et al.	2009-04-16
Pyridinoylpiperidines as 5-HT1F agonists App 20080300407 - Cohen; Michael Philip ; et al.	2008-12-04
Pyridinoylpiperidines as 5-HT.sub.1F agonists Grant 7,423,050 - Cohen , et al. September 9, 2	2008-09-09
6-N-Linked Heterocycle-Substituted 2,3,4,5-Tetrahydro-1H-Benzo[d]Azepines as 5-Ht2c Receptor Agonists App 20080214520 - Briner; Karin ; et al.	2008-09-04
Substituted (4-aminocyclohexen-1-yl)phenyl and (4-aminocyclohexen-1-yl)pyridinyl compounds as 5-HT.sub.1F agonists Grant 7,312,236 - Kohlman , et al. December 25, 2	2007-12-25
Substituted 2-carbonylamino-6-piperidinaminopyridines and substituted 1-carbonylamino-3-piperidinaminobenzenes as 5-HT1F agonists App 20070270466 - Blanco-Pillado; Maria-Jesus ; et al.	2007-11-22
Substituted 2-carbonylamino-6-piperidinaminopyridines and substituted 1-carbonylamino-3-piperidinaminobenzenes as 5-HT.sub.1F agonists Grant 7,291,632 - Blanco-Pillado , et al. November 6, 2	2007-11-06
Substituted (4-aminocyclohexen-1-yl)phenyl and (4-aminocyclohexen-1-yl)pyridinyl compounds as 5-ht1f agonists App 20070078169 - Kohlman; Daniel Timothy ; et al.	2007-04-05
Substituted 2-carbonylamino-6-piperidinaminopyridines and substituted 1-carbonylamino-3-piperidinaminobenzenes as 5-ht 1f agonists App 20060287363 - Blanco-Pillado; Maria-Jesus ; et al.	2006-12-21
Pyridinoylpiperidines as 5-ht1f agonists App 20050222206 - Cohen, Michael Philip ; et al.	2005-10-06

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.